We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Transplanted Muscle Cells May Aid Damaged Hearts

By Biotechdaily staff writers
Posted on 28 Nov 2002
A study in which muscle cells were transplanted from the thighs of heart patients into their damaged hearts shows evidence of skeletal muscle cell survival and differentiation into mature muscle fibers, leading perhaps to a way to repair damaged hearts without rejection. More...
The results were presented at the 2002 Scientific Sessions of the American Heart Association in Chicago, IL (USA).

Three patients had cells from their thigh muscles injected into their heart muscle while they awaited a heart transplant, then allowed their old, damaged hearts to be examined for signs of cell growth after they received a new heart. Examination revealed that the injected cells not only survived but also began to form muscle fiber. In addition, the areas where the cells were injected showed an increase in the formation of small blood vessels. Since the muscle cells came from the patients' own bodies, none of the patients experienced an immune reaction to the transplants.

The study is based on the premise that certain kinds of cells can be expanded in culture and maintain their functional characteristics. Instead of stem cells, the study used satellite cells, which occur naturally in muscle and help repair damage by dividing and moving to injured areas. After removing cells from the quadriceps muscle, researchers treated them with enzymes to isolate the satellite cells. These were then grown in a laboratory under carefully controlled conditions to give the cells time to divide and produce 300 million cells.

One arm of the study was conducted at the University of Michigan Health System (U-M, Ann Arbor, USA) and Temple University (Chattanooga, TN, USA). This arm involved patients awaiting a heart transplant or a left ventricular assist device (LVAD). Another arm of the study, conducted at the Arizona Heart Institute (Phoenix, USA; www.azheart.com), examined how well patients tolerated different doses of transplanted muscles cells during heart bypass surgery. Indirect evidence of scar tissue regeneration was noted in these patients.

"These results give us the first indication that muscle cell transplants, even from an entirely different kind of muscle, could one day be used to help repair damaged, failing hearts without danger of rejection,” said Francis Pagani, M.D., Ph.D., head of the heart transplant program at the U-M Cardiovascular Center.




Related Links:
Univ. of Michigan
Temple Univ

Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
ESR Analyzer
TEST1 2.0
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Industry experts gather at WHX Labs Dubai to discuss how leadership must adapt as AI and automation transform the laboratory (Photo courtesy of Shutterstock)

WHX Labs in Dubai spotlights leadership skills shaping next-generation laboratories

WHX Labs in Dubai (formerly Medlab Middle East), held at Dubai World Trade Centre (DWTC) from 10–13 February, brings together international experts to discuss the factors redefining laboratory leadership,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.